Combination chemotherapy with 5-FU 1- (aminomethyl) -3- (2-chloroethyl) -3-nitrosourea (ACNU) , and mitomycin (FUM) for carcinoma of the pancreas
Meguro, S.; Kuraishi, Y.; Ichiba, K.; Abe, M.; Yoda, T.; Mikouchi, S.
Cancer Treatment Reports 66(8): 1645-1646
1982
ISSN/ISBN: 0361-5960 PMID: 6955023 Document Number: 192861
Document emailed within 1 workday
Related Documents
Zeller, W.J.; Berger, M.R.; Henne, T.; Weber, E. 1986: More than additive toxicity of the combination of 1-methyl-1-nitrosourea plus 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat Cancer Research 46(4 Part 1): 1714-1716Mineura, K.; Mori, T.; Katakura, R.; Sasaki, T. 1981: Therapeutic effects of 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) and radiation on the rat glioma No Shinkei Geka. Neurological Surgery 9(3): 257-265
Shimizu, K.; Ushio, Y.; Hayakawa, T.; Mogami, H. 1980: Combination chemotherapy with 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride and bleomycin in meningeal carcinomatosis in rats Cancer Research 40(4): 1341-1343
Cohen, M.H. 1975: Enhancement of the antitumor effect of 1,3-bis(2-chloroethyl)-1-nitrosourea by various psychotropic drugs in combination with caffeine Journal of Pharmacology and Experimental Therapeutics 194(3): 475-479
Zhang, R.X.; Dougherty, D.V.; Rosenblum, M.L. 1990: Laboratory studies of berberine used alone and in combination with 1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain tumors Chinese Medical Journal 103(8): 658-665
Safdari, H.; Mompeon, B.; Dubois, J.B.; Gros, C. 1985: Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy for the treatment of malignant gliomas of the brain: a preliminary report Surgical Neurology 24(5): 490-497
Frischer, H.; Ahmad, T. 1977: Severe generalized glutathione reductase deficiency after antitumor chemotherapy with BCNU" [1,3-bis(chloroethyl)-1-nitrosourea Journal of Laboratory and Clinical Medicine 89(5): 1080-1091
Fraile, R.J.; Samson, M.K.; Baker, L.H.; Talley, R.W. 1979: Combination chemotherapy with mitomycin C, adriamycin, and cyclophosphamide in advanced adenocarcinoma and large cell carcinoma of the lung Cancer Treatment Reports 63(11-12): 1983-1987
Abele, R.; Alberto, P.; Germano, G.; Obrecht, J.P.; Wagenknecht, L. 1976: Simultaneous combination of adriamycin, bleomycin, cyclohexyl-chloroethyl nitrosourea with dimethyl-triazeno imidazole carboxamide in the treatment of Hodgkin's lymphoma Schweizerische Medizinische Wochenschrift 106(28): 961-963
Durdyeva, E.D.; Kukushkina, G.V.; Gorbacheva, K.B. 1986: Relation between the changes in the structure and synthesis of DNA in the cells of mouse leukemia L1210 induced by 1-methyl-1-nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea Biulleten' Eksperimental'noi Biologii i Meditsiny 101(2): 192-195
Seidenfeld, J.; Komar, K.A. 1985: Chemosensitization of cultured human carcinoma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea by difluoromethylornithine-induced polyamine depletion Cancer Research 45(5): 2132-2138
Sulkes, A.; Uziely, B.; Isacson, R.; Brufman, G.; Biran, S. 1988: Combination chemotherapy in metastatic tumors of unknown origin. 5-Fluorouracil, adriamycin and mitomycin C for adenocarcinomas and adriamycin, vinblastine and mitomycin C for anaplastic carcinomas Israel Journal of Medical Sciences 24(9-10): 604-610
Yoshida, T.; Shimizu, K.; Hayakawa, T.; Mogami, H.; Sakamoto, Y.; Egawa, T. 1987: Overcoming of ACNU resistance in an ACNU-resistant subline of rat C6 glioma in vivo through enhanced effect of ACNU by calmodulin inhibitor No Shinkei Geka. Neurological Surgery 15(3): 261-267
Li, J.G.; Li, L.Y.; Jin, Y.C.; Yu, X.H.; Liu, M.Q. 1989: Pharmacological study on a new irreversible agonist of opioid receptors, 7 alpha-bis(beta-chloroethyl) aminomethyl-6, 14-endoetheno-tetrahydrooripavine Yao Xue Xue Bao 24(5): 321-325
Yasui, Y.; Suzumori, K.; Asai, H.; Yagami, Y. 1985: Combination chemotherapy with peplomycin, cis-platinum and mitomycin C in gynecologic cancer Gan no Rinsho. Japan Journal of Cancer Clinics 31(11): 1415-1421
Inoue, K.; Horikoshi, N.; Mukaiyama, T.; Ogawa, M.; Kuraishi, Y. 1989: 5-Fluorouracil, adriamycin, and mitomycin C (FAM) combination chemotherapy in adenocarcinoma of the parotid gland Gan no Rinsho. Japan Journal of Cancer Clinics 35(4): 481-485
Ozeki, H.; Ogawa, M.; Horikoshi, N.; Inoue, K.; Mukaiyama, T.; Nagamine, D.; Ito, Y.; Imajo, K.; Shinagawa, K. 1988: Combination chemotherapy of 5-fluorouracil (5-FU), adriamycin (ADM), cis-diamminedichloroplatinum (II) (CDDP) and mitomycin C (MMC) (FAP.MMC) in advanced gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(1): 91-95
Joss, R.A.; Alberto, P.; Obrecht, J.P.; Barrelet, L.; Holdener, E.E.; Siegenthaler, P.; Goldhirsch, A.; Mermillod, B.; Cavalli, F. 1984: Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposide Cancer Treatment Reports 68(9): 1079-1084
Raina, V.; Sharma, A.; Deo, S.V.; Shukla, N.K.; Mohanty, B.K.; Goel, A.; Rath, G.K. 1998: Mitoxantrone, mitomycin-C, methotrexate combination chemotherapy with radiotherapy and/or surgery in stage IIi (T4B, NO-2, M0) breast cancer Journal of the Association of Physicians of India 46(11): 926-929
Grieco, A.; Lasorella, A.; Astone, A.; Vagliviello, L.; Bartoloni, C.; Barone, C. 1984: Chemotherapy of gastrointestinal cancer in the advanced stage with a combination of 5-fluorouracil, adriamycin, mitomycin C (FAM). a non-controlled study La Clinica Terapeutica 110(4): 353-358